0

    544759

    GLPL

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Goldline Pharmaceutical Ltd Share Price Today

    Investment Returns

    Over 1 Month -1.30% Over 3 Months -25.31% Over 6 Months 0.00% Over 1 Year 0.00%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Goldline Pharmaceutical Ltd fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 40.70
    • P/E Ratio (TTM) 0.00
    • Beta -1.91
    • Book Value / share 20.99
    • Return on equity 38.74%
    • EPS (TTM) 0.00
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 1.89
    info icon alternate text

    Goldline Pharmaceutical Ltd Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 9.79
    Operating Expense 0.00
    Net Profit 1.89
    Net Profit Margin (%) 19.30
    Earnings Per Share (EPS) 2.18
    EBITDA 0.00
    Effective Tax Rate (%) 0.00
    Particulars DEC 2025 (Values in Cr)
    Revenue 7.51
    Operating Expense 0.00
    Net Profit 0.87
    Net Profit Margin (%) 11.58
    Earnings Per Share (EPS) 1.00
    EBITDA 0.00
    Effective Tax Rate (%) 0.00
    Particulars MAR 2026 (Values in Cr)
    Revenue 31.20
    Operating Expense 25.81
    Net Profit 4.12
    Net Profit Margin (%) 13.20
    Earnings Per Share (EPS) 5.97
    EBITDA 6.93
    Effective Tax Rate (%) 23.56
    Particulars MAR 2025 (Values in Cr)
    Revenue 28.06
    Operating Expense 24.18
    Net Profit 2.83
    Net Profit Margin (%) 10.08
    Earnings Per Share (EPS) 4.11
    EBITDA 5.83
    Effective Tax Rate (%) 26.42
    Particulars MAR 2024 (Values in Cr)
    Revenue 23.57
    Operating Expense 21.04
    Net Profit 1.81
    Net Profit Margin (%) 7.67
    Earnings Per Share (EPS) 4.39
    EBITDA 4.30
    Effective Tax Rate (%) 28.45
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 12.39
    ROE % 38.74
    ROCE % 27.58
    Total Debt to Total Equity 1.22
    EBITDA Margin 21.60
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 26.34
    ROE % 35.70
    ROCE % 22.26
    Total Debt to Total Equity 1.60
    EBITDA Margin 18.24
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 20.42
    ROE % 9.56
    ROCE % 12.82
    Total Debt to Total Equity 1.84
    EBITDA Margin 12.14
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 1.23
    Total Assets 26.28
    Total Liabilities 26.28
    Total Equity 10.35
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 10.78
    Return on Capital (%) 13.25
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.78
    Total Assets 22.93
    Total Liabilities 22.93
    Total Equity 7.86
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 7.87
    Return on Capital (%) 9.51
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.05
    Total Assets 19.38
    Total Liabilities 19.38
    Total Equity 5.89
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 1.32
    Return on Capital (%) 1.53
    Particulars MAR 2025 (Values in Cr)
    Net Income 3.85
    Cash from Operations 3.23
    Cash from Investing 0.16
    Cash from Financing -2.03
    Net change in Cash 0.44
    Free Cash Flow 3.44
    Particulars MAR 2024 (Values in Cr)
    Net Income 2.52
    Cash from Operations 3.11
    Cash from Investing -1.10
    Cash from Financing -1.07
    Net change in Cash 0.73
    Free Cash Flow 4.22
    Particulars MAR 2023 (Values in Cr)
    Net Income 0.40
    Cash from Operations 2.42
    Cash from Investing -1.03
    Cash from Financing -1.44
    Net change in Cash -0.08
    Free Cash Flow 3.53
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.72 13.52 1.58 250.74 23.12 38.85
    BLISS GVS PHARMA LTD 506.15 40.69 4.49 5368.04 118.35 552.90
    CIPLA LTD. 1458.45 30.95 3.42 117820.20 1165.55 1672.20
    FERMENTA BIOTECH LTD. 345.85 15.26 2.50 1017.87 256.40 399.00
    GLAXOSMITHKLINE PHARMA LT 2392.75 42.13 17.87 40534.63 2088.00 3362.55
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.72 22.88 4.21 250.74 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 536.85 24.06 4.19 1552.07 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8297.90 108.37 23.76 20744.75 7630.00 9850.00
    BLISS GVS PHARMA LTD 506.15 54.72 4.64 5368.04 118.35 552.90

    Goldline Pharmaceutical Ltd shareholding pattern

    Holding
    29.73%
    57.29%
    5.15%
    7.81%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    Goldline Pharmaceutical Ltd Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    42.40 0.40 redarrow
    red-green-graph indicator
    16 Bearish
    0 Bullish
    • 5 Days 42.70
    • 26 Days 44.90
    • 10 Days 43.30
    • 50 Days 45.50
    • 12 Days 43.50
    • 100 Days 45.50
    • 20 Days 44.30
    • 200 Days 45.50
    42.23 PIVOT
    First Support 42.23 First Resistance 42.23 Second Support 42.23 Second Resistance 42.23 Third Support 42.23 Third Resistance 42.23
    RSI 35.63 ADX 8.76 MACD -1.40 Williams % R -84.86 Commodity Channel Index (CCI) -88.61
    Date 2026-07-03 Week 31800.00 Same Day 75000.00 Month 82500.00
    1 Year -1.92 3 Year -1.84
    Over 1 Month
    -1.30% down
    Over 1 Year
    0.00% down
    Over 3 Months
    -25.31% down
    Over 3 Years
    0.00% down
    Over 6 Months
    0.00% down
    Over 5 Years
    0.00% down

    Goldline Pharmaceutical Ltd Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Goldline Pharmaceutical Ltd?

    Answer Field

    Goldline Pharmaceutical Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 42.40 as on Jul 03 2026 03:29 PM.

    What is the Market Cap of Goldline Pharmaceutical Ltd Share?

    Answer Field

    The market cap of Goldline Pharmaceutical Ltd for NSE ₹ 0.00 & for BSE ₹ 40.70 as on Jul 03 2026 03:29 PM.

    What is the 52 Week High and Low of Goldline Pharmaceutical Ltd?

    Answer Field

    The 52 Week High and Low of Goldline Pharmaceutical Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 60.00 and ₹ 41.41.

    What is 1 year return for Goldline Pharmaceutical Ltd?

    Answer Field

    The 1 year returns on the stock has been 0.00%.

    What is the P/E Ratio of Goldline Pharmaceutical Ltd Share?

    Answer Field

    As on Jul 03 2026 03:29 PM the price-to-earnings (PE) ratio for Goldline Pharmaceutical Ltd share is 0.00.

    What is the PB ratio of Goldline Pharmaceutical Ltd Share?

    Answer Field

    As on Jul 03 2026 03:29 PM, the price-to-book (PB) ratio for Goldline Pharmaceutical Ltd share is 20.99.

    How to Buy Goldline Pharmaceutical Ltd Share?

    Answer Field

    You can trade in Goldline Pharmaceutical Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Goldline Pharmaceutical Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Goldline Pharmaceutical Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Goldline Pharmaceutical Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |